«Yellow Fever

Below is an extended Yellow Fever patents listing. Click here to return to the Yellow Fever main in depth entry.

Patents :
US Patent No.	Title
7378422	Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
7390619	Optimization of immunomodulatory properties of genetic vaccines
7390637	Keratinocyte derived interferon
7390646	Bacterial vectors and methods of use thereof
7390881	Recombinant therapeutic fusion proteins
7390884	Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease
7393662	Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
7393856	Anti-viral uses of borinic acid complexes
7393922	Insecticidal Cry4Ba proteins with enhanced toxicity
7393928	Recombinant gelatins
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7390495	Neurovirulent strain of the West Nile virus and uses thereof
7388017	Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
7387900	Colloidal metal compositions and methods
7379765	Oxygen enhancing membrane systems for implantable devices
7380369	Insect trap and method of use
7381431	Insect repellent
7381800	Antibodies to HBIMF63 polypeptide
7381807	Immunostimulatory oligonucleotides and uses thereof
7384785	Diagnostic test for West Nile virus
7384909	Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
7384924	Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
7385032	Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
7387271	Immunostimulatory combinations
7396796	Treatment agent, method and device for treating hazardous substances
7396827	Pharmaceutical compositions and treatment methods
7413733	Antigen transduced T cells used as a delivery system for antigens
7413851	Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7414031	5-nitro-nucleoside compounds for treating viral infections
7416733	Flavivirus fusion inhibitors
7416745	Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters
7416840	Replication of hepatitis C virus in non-hepatic epithelial and mouse hepatic cells
7417029	Prodrug of an ice inhibitor
7417121	Human G-protein coupled receptor, HGPRBMY39
7417136	Nucleic acid vaccines for prevention of flavivirus infection
7419787	Mass spectrometric methods for detecting mutations in a target nucleic acid
7411051	Antibodies to HDPPA04 polypeptide
7410975	Small molecule toll-like receptor (TLR) antagonists
7410956	Caspase inhibitor prodrugs
7399472	Vaccines
7399473	Virus coat protein/receptor chimeras and method of use
7402572	Immunostimulatory nucleic acid molecules
7402608	Compounds and methods for the treatment or prevention of Flavivirus infections
7404960	Multivalent vaccine composition having increased stability of capsular polysaccharide
7405046	Compositions and methods for treatment of rhinovirus
7407662	Modified viral particles with immunogenic properties and reduced lipid content
7407663	Modified immunodeficiency virus particles
7407758	HCV variants
7407964	Caspase inhibitors and uses thereof
7419789	Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.